+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Disulfiram Market - Global Forecast 2026-2032- Product Image
Disulfiram Market - Global Forecast 2026-2032- Product Image
New

Disulfiram Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 182 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082578
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The disulfiram market is evolving within the global addiction therapeutics landscape, driven by established clinical roles, increased adoption of digital adherence solutions, and recent changes in policy and supply chain practices. Strategic decision-makers need this report to navigate the interplay between clinical evidence, evolving care models, and operational resilience.

Market Snapshot: Disulfiram Market Size and Growth Outlook

The Disulfiram Market grew from USD 412.73 million in 2025 to USD 434.34 million in 2026. It is expected to continue growing at a CAGR of 5.36%, reaching USD 595.23 million by 2032.

Scope & Segmentation of the Disulfiram Market

  • Manufacturer Types: Includes both branded and generic producers, shaping competition around product innovation, pricing strategies, and formulary access.
  • Indication Subgroups: Covers Alcohol Dependence (with Initial and Maintenance Therapy) and Off-Label Uses (such as psychiatric and substance use disorders), highlighting implications for product positioning, trial activity, and label expansion.
  • Distribution Channels: Spans hospital, online, and retail pharmacy segments, each with unique regulatory and logistic environments affecting patient access and education.
  • End-User Contexts: Inpatient and outpatient settings inform initiation patterns, monitoring, and long-term management practices, influencing support requirements.
  • Dosage Options: Focuses on both 250 mg and 500 mg formulations, reflecting on prescribing habits, pill burden, and adherence trends.
  • Therapy Regimens: Examines monotherapy and combination therapy (including with acamprosate and naltrexone), relevant to evolving clinical evidence and co-prescribing considerations.
  • Regional Coverage: Assesses Americas, Europe Middle East & Africa, and Asia-Pacific to capture regulatory, distribution, and care-practice nuances.

Key Takeaways for Senior Decision-Makers

  • Disulfiram remains a cornerstone in alcohol addiction pharmacotherapy, yet contemporary care increasingly combines it with other agents or psychosocial supports for improved outcomes.
  • Clinical research momentum is growing in off-label and co-occurring disorder contexts, necessitating agile evidence-generation and awareness strategies among providers and payers.
  • Manufacturers and distributors are strengthening supply chains and adopting digital adherence technologies to support patient retention and therapy effectiveness in both inpatient and outpatient models.
  • Regional disparities in regulatory frameworks and care delivery demand localized market entry, sourcing strategies, and tailored channel partnerships to maintain access and compliance.
  • Competitive success hinges on the ability to align robust sourcing, flexible manufacturing, and integrated channel partnerships—including telemedicine and specialty pharmacies—to mitigate operational risk and facilitate patient-centric care.

Tariff Impact on Supply Chains and Access

Recent United States tariff changes have significantly altered supply-chain dynamics for disulfiram. Manufacturers are diversifying suppliers, nearshoring production processes, and revisiting procurement agreements to manage cost volatility and ensure uninterrupted product availability. These adjustments affect pricing, commercial contracting, and overall patient access, placing renewed emphasis on supply resilience and downstream inventory strategies. Strategic coordination with regulatory bodies, payers, and distribution partners is facilitating the operational agility required to respond to these fluctuations without compromising patient care.

Methodology & Data Sources

This research combines primary interviews with clinicians, pharmacists, payers, and supply-chain executives alongside a thorough literature and regulatory review. Quantitative triangulation validates clinical and operational trends, with supply-chain mapping and stakeholder consultation ensuring findings reflect practical market realities.

Why This Report Matters

  • Provides senior decision-makers with strategic clarity on market segmentation, supply-chain vulnerabilities, and evolving competitive dynamics.
  • Enables proactive planning for regulatory or tariff disruptions, ensuring sustainable patient access and long-term market viability.
  • Supports cross-functional teams by translating clinical research and real-world data into actionable product development and commercial pathways.

Conclusion

The disulfiram market of today is defined by multi-layered clinical, regulatory, and operational dynamics. Organizations that prioritize evidence-based strategies, patient-focused access, and resilient operations will sustain competitive advantage and reliable patient outcomes as the market landscape advances.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Disulfiram Market, by Route Of Administration
8.1. Oral
8.2. Implantable
9. Disulfiram Market, by Dosage Form
9.1. Tablet
9.2. Implant
9.3. Compounded Formulations
10. Disulfiram Market, by End User
10.1. Hospitals
10.1.1. Public Hospitals
10.1.2. Private Hospitals
10.2. Rehabilitation Centers
10.3. Specialty Clinics
10.3.1. Addiction Treatment Clinics
10.3.2. Mental Health Clinics
10.4. Home Care
10.4.1. Self Administration
10.4.2. Caregiver Administration
11. Disulfiram Market, by Brand Type
11.1. Branded
11.2. Generic
12. Disulfiram Market, by Packaging Format
12.1. Blister Packs
12.2. Bottles
13. Disulfiram Market, by Therapy Line
13.1. First Line
13.2. Second Line
13.3. Third Line Or Later
14. Disulfiram Market, by Region
14.1. Americas
14.1.1. North America
14.1.2. Latin America
14.2. Europe, Middle East & Africa
14.2.1. Europe
14.2.2. Middle East
14.2.3. Africa
14.3. Asia-Pacific
15. Disulfiram Market, by Group
15.1. ASEAN
15.2. GCC
15.3. European Union
15.4. BRICS
15.5. G7
15.6. NATO
16. Disulfiram Market, by Country
16.1. United States
16.2. Canada
16.3. Mexico
16.4. Brazil
16.5. United Kingdom
16.6. Germany
16.7. France
16.8. Russia
16.9. Italy
16.10. Spain
16.11. China
16.12. India
16.13. Japan
16.14. Australia
16.15. South Korea
17. United States Disulfiram Market
18. China Disulfiram Market
19. Competitive Landscape
19.1. Market Concentration Analysis, 2025
19.1.1. Concentration Ratio (CR)
19.1.2. Herfindahl Hirschman Index (HHI)
19.2. Recent Developments & Impact Analysis, 2025
19.3. Product Portfolio Analysis, 2025
19.4. Benchmarking Analysis, 2025
19.5. Bausch Health Companies Inc.
19.6. Cipla Ltd.
19.7. Dr. Reddy's Laboratories Ltd.
19.8. Glenmark Pharmaceuticals Ltd.
19.9. Lupin Limited
19.10. Sandoz International GmbH
19.11. Sun Pharmaceutical Industries Ltd.
19.12. Teva Pharmaceutical Industries Ltd.
19.13. Torrent Pharmaceuticals Limited
19.14. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DISULFIRAM MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DISULFIRAM MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL DISULFIRAM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. UNITED STATES DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 14. CHINA DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DISULFIRAM MARKET SIZE, BY ORAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DISULFIRAM MARKET SIZE, BY ORAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DISULFIRAM MARKET SIZE, BY ORAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANTABLE, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANTABLE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DISULFIRAM MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DISULFIRAM MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DISULFIRAM MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANT, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DISULFIRAM MARKET SIZE, BY IMPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DISULFIRAM MARKET SIZE, BY COMPOUNDED FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DISULFIRAM MARKET SIZE, BY COMPOUNDED FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DISULFIRAM MARKET SIZE, BY COMPOUNDED FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DISULFIRAM MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DISULFIRAM MARKET SIZE, BY PUBLIC HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DISULFIRAM MARKET SIZE, BY PUBLIC HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DISULFIRAM MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DISULFIRAM MARKET SIZE, BY PRIVATE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DISULFIRAM MARKET SIZE, BY PRIVATE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DISULFIRAM MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DISULFIRAM MARKET SIZE, BY REHABILITATION CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DISULFIRAM MARKET SIZE, BY REHABILITATION CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DISULFIRAM MARKET SIZE, BY ADDICTION TREATMENT CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DISULFIRAM MARKET SIZE, BY ADDICTION TREATMENT CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DISULFIRAM MARKET SIZE, BY ADDICTION TREATMENT CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DISULFIRAM MARKET SIZE, BY MENTAL HEALTH CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DISULFIRAM MARKET SIZE, BY MENTAL HEALTH CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DISULFIRAM MARKET SIZE, BY MENTAL HEALTH CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DISULFIRAM MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DISULFIRAM MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DISULFIRAM MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DISULFIRAM MARKET SIZE, BY SELF ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DISULFIRAM MARKET SIZE, BY SELF ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DISULFIRAM MARKET SIZE, BY SELF ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DISULFIRAM MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DISULFIRAM MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DISULFIRAM MARKET SIZE, BY CAREGIVER ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DISULFIRAM MARKET SIZE, BY BRANDED, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DISULFIRAM MARKET SIZE, BY BRANDED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DISULFIRAM MARKET SIZE, BY BRANDED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DISULFIRAM MARKET SIZE, BY GENERIC, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DISULFIRAM MARKET SIZE, BY GENERIC, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DISULFIRAM MARKET SIZE, BY GENERIC, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DISULFIRAM MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DISULFIRAM MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DISULFIRAM MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DISULFIRAM MARKET SIZE, BY BOTTLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DISULFIRAM MARKET SIZE, BY BOTTLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DISULFIRAM MARKET SIZE, BY BOTTLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DISULFIRAM MARKET SIZE, BY FIRST LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DISULFIRAM MARKET SIZE, BY FIRST LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DISULFIRAM MARKET SIZE, BY FIRST LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DISULFIRAM MARKET SIZE, BY SECOND LINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DISULFIRAM MARKET SIZE, BY SECOND LINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DISULFIRAM MARKET SIZE, BY SECOND LINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DISULFIRAM MARKET SIZE, BY THIRD LINE OR LATER, BY REGION, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DISULFIRAM MARKET SIZE, BY THIRD LINE OR LATER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DISULFIRAM MARKET SIZE, BY THIRD LINE OR LATER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DISULFIRAM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. AMERICAS DISULFIRAM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 79. AMERICAS DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 80. AMERICAS DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 81. AMERICAS DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. AMERICAS DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 83. AMERICAS DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 84. AMERICAS DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 88. NORTH AMERICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. NORTH AMERICA DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 90. NORTH AMERICA DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 91. NORTH AMERICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 92. NORTH AMERICA DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 98. LATIN AMERICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. LATIN AMERICA DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 100. LATIN AMERICA DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. EUROPE DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. EUROPE DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 121. EUROPE DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 122. EUROPE DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 125. EUROPE DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 126. EUROPE DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 127. EUROPE DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 133. MIDDLE EAST DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 138. AFRICA DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. AFRICA DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 140. AFRICA DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 141. AFRICA DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 142. AFRICA DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 143. AFRICA DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 144. AFRICA DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 146. AFRICA DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 147. AFRICA DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 150. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 151. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL DISULFIRAM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 159. ASEAN DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 160. ASEAN DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 161. ASEAN DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 162. ASEAN DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 163. ASEAN DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 164. ASEAN DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 165. ASEAN DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 166. ASEAN DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 167. ASEAN DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 168. ASEAN DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 169. GCC DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 170. GCC DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. GCC DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 172. GCC DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 173. GCC DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 174. GCC DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 175. GCC DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 176. GCC DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 178. GCC DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 179. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 189. BRICS DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 191. BRICS DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 192. BRICS DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 193. BRICS DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 194. BRICS DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 195. BRICS DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 196. BRICS DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 197. BRICS DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 198. BRICS DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 199. G7 DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 200. G7 DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 201. G7 DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 202. G7 DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 203. G7 DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 204. G7 DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 205. G7 DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 206. G7 DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 207. G7 DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 208. G7 DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 209. NATO DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 210. NATO DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. NATO DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 212. NATO DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. NATO DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 214. NATO DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 215. NATO DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 216. NATO DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 217. NATO DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 218. NATO DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL DISULFIRAM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 226. UNITED STATES DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 227. UNITED STATES DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 228. UNITED STATES DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 229. UNITED STATES DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)
TABLE 230. CHINA DISULFIRAM MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 231. CHINA DISULFIRAM MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 232. CHINA DISULFIRAM MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
TABLE 233. CHINA DISULFIRAM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 234. CHINA DISULFIRAM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
TABLE 235. CHINA DISULFIRAM MARKET SIZE, BY SPECIALTY CLINICS, 2018-2032 (USD MILLION)
TABLE 236. CHINA DISULFIRAM MARKET SIZE, BY HOME CARE, 2018-2032 (USD MILLION)
TABLE 237. CHINA DISULFIRAM MARKET SIZE, BY BRAND TYPE, 2018-2032 (USD MILLION)
TABLE 238. CHINA DISULFIRAM MARKET SIZE, BY PACKAGING FORMAT, 2018-2032 (USD MILLION)
TABLE 239. CHINA DISULFIRAM MARKET SIZE, BY THERAPY LINE, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Disulfiram market report include:
  • Bausch Health Companies Inc.
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Glenmark Pharmaceuticals Ltd.
  • Lupin Limited
  • Sandoz International GmbH
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Torrent Pharmaceuticals Limited
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 434.34 Million
Forecasted Market Value ( USD ) by 2032 $ 595.23 Million
Compound Annual Growth Rate5.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Disulfiram (CAS 97-77-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Disulfiram (CAS 97-77-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Alcohol Use Disorder Market - Global Forecast 2026-2032 - Product Image

Alcohol Use Disorder Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Addiction Disorders Drugs Market - Global Forecast 2026-2032 - Product Image

Addiction Disorders Drugs Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Addictions Therapeutics Market Report 2025 - Product Image

Addictions Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2025 - Product Image

Cocaine Use Disorder - Pipeline Insight, 2025

  • Clinical Trials
  • 50 Pages
  • Global
From

About the Disulfiram Market

The Disulfiram market is a segment of the Addiction Disorders Drugs market. Disulfiram is a medication used to treat alcohol use disorder (AUD). It works by blocking the breakdown of alcohol, causing unpleasant side effects when alcohol is consumed. It is used as an aid to help people abstain from drinking alcohol. Disulfiram is available in tablet form and is taken orally. It is also available in an injectable form. The Disulfiram market is highly competitive, with many companies offering generic versions of the drug. Companies in the market include Mylan, Teva Pharmaceuticals, Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.